ISM

Clinical trials for ISM explained in plain language.

Never miss a new study

Get alerted when new ISM trials appear

Sign up with your email to follow new studies for ISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for mastocytosis patients: drug trial targets debilitating symptoms

Symptom relief Ongoing

This study tests an experimental drug called bezuclastinib (CGT9486) in adults with nonadvanced systemic mastocytosis, a rare disease where too many mast cells cause symptoms like flushing, itching, and stomach issues. About 237 participants will receive either the drug or a plac…

Matched conditions: ISM

Phase: PHASE2 • Sponsor: Cogent Biosciences, Inc. • Aim: Symptom relief

Last updated May 15, 2026 11:55 UTC

ISM

Get alerted when new ISM trials appear

New hope for mastocytosis patients: drug trial targets debilitating symptoms